Column Group II GP, LP
CIK 1645333 · last filed 2022-05-23
Column Group II GP, LP is a corporate insider who has filed 9 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider bought $5.3M of NGM on May 23, 2022. Across all open-market trades the lifetime net is −$182.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $74.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$73.96M
4
9
-$182.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 11,118,333 | $1.54 | $17.12M | $16.66M | 2 | 2022-05-23 |
| ORIC | 10%+ Owner | 3,855,883 | $8.27 | $31.89M | $0 | 1 | 2021-11-16 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | 10%+ Owner | 2,610,769 | $58.01 | $151.45M | -$198.78M | 3 | 2021-08-24 |
| RCUS | 10%+ Owner | 1,767,676 | $23.80 | $42.07M | $0 | 1 | 2018-03-19 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-23 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +397,000 | $5.30M | EDGAR |
| 2021-11-16 | ORIC | Mixed | −5,049,345 | $1.33M | EDGAR |
| 2021-08-24 | RAPT Therapeutics, Inc. (RAPT) Delisted | Sell (S) | −957,460 | -$29.97M | EDGAR |
| 2020-09-23 | RAPT Therapeutics, Inc. (RAPT) Delisted | Sell (S) | −5,472,000 | -$168.81M | EDGAR |
| 2020-08-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +643,130 | $11.35M | EDGAR |
| 2020-06-22 | RAPT Therapeutics, Inc. (RAPT) Delisted | Other (J) | — | $0 | EDGAR |
| 2019-04-02 | — | U | −59,786,478 | -$349.75M | |
| 2018-03-19 | RCUS | Conv (C) | +24,785,950 | $0 | EDGAR |
| 2016-09-22 | — | Buy (P) | +4,000,000 | $25.00M |